Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke
- 23 July 2002
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 59 (2), 193-197
- https://doi.org/10.1212/wnl.59.2.193
Abstract
Background and Objectives: Prior ischemic stroke is a risk factor for intracerebral hemorrhage (ICH) in patients taking warfarin, but the mechanism is not known. This study investigates radiographic and clinical characteristics of patients with warfarin-related ICH following ischemic stroke. Methods: In this case-control study, the authors selected all patients with warfarin-related ICH and previous symptomatic ischemic stroke from a prospective cohort of consecutive patients with ICH. Control subjects were similarly aged patients with history of symptomatic stroke randomly chosen from an anticoagulant therapy unit. The 26 eligible ICH cases and 56 controls were compared for vascular risk factors, stroke characteristics, and extent of leukoaraiosis (graded in anterior and posterior brain regions on a validated scale of 0 to 4). Results: The presence and severity of leukoaraiosis on CT scan correlated strongly with the occurrence of ICH. Leukoaraiosis was seen in 24 of 26 cases (92%) compared with 27 of 56 controls (48%), yielding an odds ratio of 12.9 (95% CI 2.8 to 59.8). Other clinical factors associated with ICH included an international normalized ratio >3.0, history of multiple previous strokes, and the presence of carotid artery stenosis. The relationship between leukoaraiosis and ICH persisted in multivariable analyses controlling for these risk factors as well as hypertension and diabetes mellitus. Conclusions: Leukoaraiosis is an independent risk factor for warfarin-related ICH in survivors of ischemic stroke, including those in the commonly employed range of anticoagulation.Keywords
This publication has 24 references indexed in Scilit:
- Atrial Fibrillation and StrokeStroke, 2001
- Analysis of risk factors involved in oral-anticoagulant-related intracranial haemorrhagesQJM: An International Journal of Medicine, 2000
- Apolipoprotein E Genotype and the Risk of Recurrent Lobar Intracerebral HemorrhageNew England Journal of Medicine, 2000
- A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial originAnnals of Neurology, 1997
- Apolipoprotein E ε4 Is Associated With the Presence and Earlier Onset of Hemorrhage in Cerebral Amyloid AngiopathyStroke, 1996
- Oral Anticoagulants and Intracranial HemorrhageStroke, 1995
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.BMJ, 1992
- Prognostic parameters in spontaneous intracerebral hematomas with special reference to anticoagulant treatment.Stroke, 1991
- Grading white matter lesions on CT and MRI: a simple scale.Journal of Neurology, Neurosurgery & Psychiatry, 1990